U.S. Markets close in 4 hrs 18 mins

United Therapeutics Corporation (UTHR)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
132.49+1.55 (+1.18%)
As of 11:40AM EDT. Market open.
People also watch
ALXNBMRNVRTXMDCOMYGN
Full screen
Previous Close130.94
Open132.01
Bid132.30 x 100
Ask132.39 x 100
Day's Range131.07 - 132.66
52 Week Range100.70 - 169.89
Volume100,380
Avg. Volume608,281
Market Cap5.97B
Beta1.33
PE Ratio (TTM)9.30
EPS (TTM)14.24
Earnings DateJul 26, 2017 - Jul 31, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est125.09
Trade prices are not sourced from all markets
  • Barrons.com4 days ago

    [$$] Biotech Blazes Higher

    It takes just one match to start a fire, but last week the biotech sector got two. Investors should take care not to get burned. The sector got a boost not only from the Senate’s health-care plan, which made nary a mention of the high cost of drugs, but also from a draft of an executive order by President Donald Trump, which appeared to remove the threat of imminent action to rein in prices.

  • GuruFocus.com8 days ago

    Argan and Sturm Ruger Show High Profit and Low Debt

    Five recommendations

  • American City Business Journals14 days ago

    Silver Spring tissue regeneration company raises $12 million

    HighCape Partners, a New York equity fund and majority owner of Aziyo, led the funding round for the local company, which creates customized human tissue products for use in orthopedic, spinal, sports medicine and dermal surgeries. Several of its products are allografts — or tissue grafts from donors — for bone repair, ligament replacement and skin grafts.